Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively as margin compression and operational investments weighed on sentiment.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Vertex Pharmaceuticals said Thursday that its closely watched drug, suzetrigine, ...

Forbes contributors publish independent expert analyses and insights. Mark Murphy covers leadership, hiring and employee engagement. What is a situational interview question? In short, situational ...

Community driven content discussing all aspects of software development from DevOps to design patterns. When presented with a tricky Java interview question like this, most job candidates will try to ...

Vertex is severing one of its ties to CRISPR Therapeutics. The big biotech has chosen to opt out of the diabetes gene-edited stem cell therapy it gained through the acquisition of ViaCyte, leaving ...

Vertex’s decision to double down on a pain program has delivered a phase 2 win. The biotech linked its NaV1.8 inhibitor VX-548 to statistically significant improvements in pain intensity in people ...

For the first time, U.S. regulators have cleared a treatment using CRISPR, the gene-editing technology, for patients. The product is Casgevy, a treatment for sickle cell disease and beta thalassemia, ...

Forbes contributors publish independent expert analyses and insights. Dr. Tracy Brower writes about joy, community and the future of work. When you get to a second interview, you’re in a positive ...

I've got 40 years C experience, mostly with device drivers and OS internals (helped port Linux to the SH-4 back in 2000). I retired a few years back (thank you Qualcomm), and learned Java to scratch ...

If you're seeking a DevOps or developer position, where you will handle the runtime management of Java applications, you'll need to answer important Java garbage collection interview questions to land ...